DNA damage and transcription stress cause ATP-mediated redesign of metabolism and potentiation of anti-oxidant buffering

Accumulation of DNA lesions causing transcription stress is associated with natural and accelerated aging and culminates with profound metabolic alterations. Our understanding of the mechanisms governing metabolic redesign upon genomic instability, however, is highly rudimentary. Using Ercc1-defective mice and Xpg knock-out mice, we demonstrate that combined defects in transcription-coupled DNA repair (TCR) and in nucleotide excision repair (NER) directly affect bioenergetics due to declined transcription, leading to increased ATP levels. This in turn inhibits glycolysis allosterically and favors glucose rerouting through the pentose phosphate shunt, eventually enhancing production of NADPH-reducing equivalents. In NER/TCR-defective mutants, augmented NADPH is not counterbalanced by increased production of pro-oxidants and thus pentose phosphate potentiation culminates in an over-reduced redox state. Skin fibroblasts from the TCR disease Cockayne syndrome confirm results in animal models. Overall, these findings unravel a mechanism connecting DNA damage and transcriptional stress to metabolic redesign and protective antioxidant defenses.

X D A description of all covariates tested D X A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons D X A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals) □ X For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.
X D For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings D X For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes D X Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.

Software and code
Policy information about availability of computer code Data collection

Data analysis
Expression intensities were normalized using RMA as is implemented in R open statistical package (http://www.r-project.org/). Linear model from Gentleman implemented in R 53 was used.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.

Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: The data supporting the findings of the study are available from the corresponding author upon reasonable request.
The datasets generated and/or analysed in figure 1C, supplementary table 1-5 are available in the ArrayExpress repository, accession code E-MEXP-1503, https://www.ebi.ac.uk/arrayexpress/. Source data for the figures provided are available as a Source Data file.

Field-specific reporting
Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.

Behavioural & social sciences study design
All studies must disclose on these points even when the disclosure is negative.

Ecological, evolutionary & environmental sciences study design
All studies must disclose on these points even when the disclosure is negative.

Research sample
Sampling strategy

Data collection
Describe the data collection procedure, including who recorded the data and haw.

I
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. D Tick this box to confirm that the raw and calibrated dates are available in the paper or in Supplementary Information.

Animals and other organisms
Policy information about studies involving animals: ARRIVE guidelines recommended for reporting animal research Note that full information on the approval of the study protocol must also be provided in the manuscript.

Human research participants
Policy information about studies involving human research participants Note that full information on the approval of the study protocol must also be provided in the manuscript.

Clinical data
Policy information about clinical studies All manuscripts should comply with the ICMJE guidelines for publication of clinical research and a completed CONSORT checklist must be included with all submissions. Describe the methods used to ensure data quality in full detail, including how many peaks are at FDR 5% and above 5-fold enrichment.
Describe the software used to collect and analyze the Ch IP-seq data. For custom code that has been deposited into a community repository, provide accession details.
Confirm that: X The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
X The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
X All plots are contour plots with outliers or pseudocolor plots.
X A numerical value for number of cells or percentage (with statistics) is provided.

Cell population abundance Population was homogeneous and derived from cultured plates
Gating strategy no gating strategy was applied D Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.

Experimental design
Design type Indicate task or resting state; event-related or block design.

Design specifications
Specify the number of blocks, trials or experimental units per session and/or subject, and specify the length of each trial or block (if trials are blocked) and interval between trials.

Behavioral performance measures
State number and/or type of variables recorded (e.g. correct button press, response time) and what statistics were used to establish that the subjects were performing the task as expected (e.g. mean, range, and/or standard deviation across subjects). .I